Dideoxycytidine, an analog of pyrimidine, is a nucleoside analog reverse transcriptase inhibitor (NRTI) with antiretroviral activity.

Lamivudine is a potent nRTI (nucleoside analog reverse transcriptase inhibitor) an analogue of cytidine,which can inhibit both HIV 1 and 2 reverse transcriptase as well as the reverse transcriptase of hepatitis B.

Tenofovir disoproxil fumarate can block reverse transcriptase which has antiviral activity against HBV and HIV-1.

Tenofovir is a nucleotide analogue reverse transcriptase inhibitors (NRTIs) which reduces the viral cytopathic effect of HIV-1 (IIIB), HIV-2(ROD) with EC50 of 1.15 μg/ml and 1.12 μg/ml.

Tenofovir dsoproxil acts as an anti-HIV agent and a reverse transcriptase inhibitor that is used to prevent HIV/AIDS and chronic hepatitis B.

Adefovir dipivoxil can block reverse transcriptase which is crucial for the hepatitis B virus (HBV) to reproduce.

Zidovudine is a reverse-transcriptase inhibitor (NRTI) that is used to the treat HIV/AIDS infection.

Adefovir is a NRTI used for treatment of hepatitis B and herpes simplex virus infection.

Abacavir is a powerful nucleoside analog reverse transcriptase inhibitor (NRTI) used to treat HIV and AIDS.

Didanosine is an inhibitor of reverse transcriptase with IC50 of 0.49 μM.

Abacavir Hemisulfate is a competitive and brain-penetrant reverse transcriptase inhibitor.

GS-7340 Fumarate, the prodrug of tenofovir, is a reverse transcriptase inhibitor that can prevent HIV from multiplying.

GS-7340 hemifumarate is a prodrug of Tenofovir (TFV) that can block the HIV-1nucleotide reverse transcriptase.

Stavudine, a nucleoside analog, inhibits reverse transcriptase of HIV.

Emtricitabine is a reverse transcriptase inhibitor used to treat HIV infection.

Remdesivir is an nucleotide-analog antiviral prodrug. Remdesivir could inhibit SARS-CoV-2 3CLpro main protease.

GS-7340 is the prodrug of tenofovir which inhibits reverse transcriptase and is used to treat HIV and hepatitis B.

Tenofovir is an antiretroviral drug known as nucleotide analogue reverse transcriptase inhibitors (NRTIs), which block reverse transcriptase, a crucial virus enzyme in HIV-1 and HBV.